Marc Vaillancourt - Concepedia

Author

Marc Vaillancourt

Université de Montréal

Also Known As

M Vaillancourt, M. Vaillancourt, Marc Vaillancourt, Vaillancourt, Marc

Publications

244

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Toronto General Hospital Western University Queen Elizabeth II Health Sciences Centre Montreal Clinical Research Institute

About

Marc Vaillancourt is an author at Université de Montréal specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	160
2	Natural Sciences	3	3	52
3	Biochemistry	3	3	52
4	Chemical Biology	1	1	19
5	Chemistry	1	1	21

Marc Vaillancourt

Publications

232

Citations

H-Index

Page 1

	Year	Citations
Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease Daniel Lamarre, G Croteau, Elizabeth Wardrop, Antimicrobial Agents and Chemotherapy Potent InhibitorMedicineImmunologyAntiviral ResponseAnti-hiv-1 Activity	1997	74
The HIV Type 1 Protease Inhibitor Saquinavir Can Select for Multiple Mutations that Confer Increasing Resistance Marc Vaillancourt, David M. Irlbeck, Terri Smith, AIDS Research and Human Retroviruses Protease Inhibitor SaquinavirMultiple MutationsHuman RetrovirusGeneticsImmunology	1999	28
Cyclosporine Reduction in the Presence of Everolimus: 3-Month Data From a Canadian Pilot Study of Maintenance Cardiac Allograft Recipients Heather J. Ross, Peter W. Pflugfelder, Haissam Haddad, The Journal of Heart and Lung Transplantation 3-Month DataHeart FailureTransplantationCardiogenic ShockCardiovascular Disease	2008	27
Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study Heather J. Ross, Peter W. Pflugfelder, Haissam Haddad, Transplant International	2009	25
Design and synthesis of a new Sialyl Lewis X Mimetic: How selective are the selectin receptors? Marc De Vleeschauwer, Marc Vaillancourt, Nathalie Goudreau, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryHeterocyclicBiochemistryFunctional SelectivityNatural Sciences	2001	21
A New Approach to Explore the Binding Space of Polysaccharide-Based Ligands: Selectin Antagonists Mickael Calosso, Daniel Charpentier, Marc Vaillancourt, ACS Medicinal Chemistry Letters Polysaccharide LigandGlycobiologyPolysaccharideChemical BiologyMedicinal Chemistry	2012	19
A Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection Eric M. Yoshida, Leslie Lilly, Paul J. Marotta, Annals of Hepatology	2013	16
Difunctional enols of N-protected amino acids as low molecular weight and novel inhibitors of HIV-1 protease. Marc Vaillancourt, Benoit Vanasse, Éric A. Cohen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryHiv-1 ProteaseBiochemistryLow Molecular WeightMedicine	1993	12
Acyclic Tethers Mimicking Subunits of Polysaccharide Ligands: Selectin Antagonists Mickael Calosso, Guillaume Tambutet, Daniel Charpentier, ACS Medicinal Chemistry Letters	2014	10

Page 1